Sign In
Buy UBS
$53.57
+0.110 (+0.206%)
At Close: Aug 05, 2026
Kymera Therapeutics to Present in Fireside Chat at the UBS Virtual Targeted Protein Degradation Day
07:00am, Tuesday, 09'th Jul 2024
WATERTOWN, Mass., July 09, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targete
Nvidia stock price target gets boost from UBS, Wolfe Research
04:20pm, Monday, 08'th Jul 2024
Nvidia (NVDA) shares edge higher Monday as analysts from UBS and Wolfe Research raise their price targets on the chip stock to $150 per share. Market Domination's Josh Lipton and Julie Hyman talk abou
UBS leans into Bank of America ahead of micro-focused bank earnings
01:22pm, Monday, 08'th Jul 2024
UBS analysts on Monday called Bank of America Corp. the “most interesting money center,” as major banks approach second-quarter earnings season later this week.
Nvidia share price target hiked by UBS as supply chain reals strong AI-related demand
01:02pm, Monday, 08'th Jul 2024
NVIDIA Corp (NASDAQ:NVDA, ETR:NVD) was a key driving force on Wall Street on Monday after UBS upped its target price, based on supply chain checks. Investor sentiment about the chip giant “has fade
UBS upgrades PNC Financial to buy
11:50am, Monday, 08'th Jul 2024
Erika Najarian, UBS large cap bank and consumer finance analyst, joins 'Squawk on the Street' to discuss how to pick the winners among the financials, why Najarian favors PNC, and more.
Why Nvidia's stock can scale the ‘wall of worry,' according to UBS
10:11am, Monday, 08'th Jul 2024
Nvidia Corp.'s stock is still well-loved on Wall Street, but UBS analyst Timothy Arcuri notes that sentiment “has faded somewhat in recent weeks.”
Monte Rosa Therapeutics to Present at the UBS Targeted Protein Degradation Day
08:36am, Monday, 08'th Jul 2024
BOSTON, July 08, 2024 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today ann
C4 Therapeutics to Participate in the Virtual UBS Targeted Protein Degradation Day
07:00am, Monday, 08'th Jul 2024
WATERTOWN, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science,
Bristol Myers Squibb to Participate in UBS Virtual Targeted Protein Degradation Day
06:59am, Monday, 08'th Jul 2024
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb to Participate in UBS Virtual Targeted Protein Degradation Day.
SNB's Jordan blames Credit Suisse bosses for bank's crash
11:11am, Friday, 05'th Jul 2024
Credit Suisse's collapse was caused by the bank's management, not by Swiss financial authorities, Swiss National Bank Chairman Thomas Jordan was quoted as saying on Friday.
Direct Line to emphasise dividend payouts at markets day, suggests UBS
09:02am, Friday, 05'th Jul 2024
Direct Line Insurance Group PLC's (LSE:DLG) capital markets day on Wednesday, July 10, will see a focus on three areas according to UBS, with dividends likely to be central to the discussion. “We an
BNP, UBS said to show Interest in HSBC's German Wealth Unit, Bloomberg News reports
01:17pm, Thursday, 04'th Jul 2024
HSBC is attracting initial interest from peers including BNP Paribas SA and UBS Group AG , for the sale of its German wealth-management unit, Bloomberg News reported on Thursday citing people familiar
State Street replaces UBS as custodian bank for Swiss government fund
12:02pm, Wednesday, 03'rd Jul 2024
U.S. bank State Street has won a mandate to act as custodian bank for a multibillion-dollar compensation fund of the Swiss federal government that was previously at UBS , authorities said on Wednesday
BAE Systems tipped for steady first half at UBS
07:01am, Wednesday, 03'rd Jul 2024
BAE Systems PLC (LSE:BA.) is expected to report first-half numbers on 1 August with expectations moderating a little in recent weeks.
BP shares to re-rate as greening initiatives take back seat, suggests UBS
06:12am, Wednesday, 03'rd Jul 2024
BP PLC (LSE:BP.) is due for a slow re-rating from this point onwards, suggests UBS, as self-help measures and a steady retreat from its green initiatives feed through into higher earnings.
